Table 1.
The baseline characteristics of patients.
| Characteristics | Values (n = 28) |
|---|---|
| Age (years) † | 73.5 (56, 89) |
| Sex * | |
| Male/Female | 22 (79)/6 (21) |
| Etiology * | |
| HBV/HCV/non-viral | 1 (4)/12 (43)/15 (53) |
| ECOG PS * | |
| 0/1/2 | 25 (89)/2 (7)/1 (4) |
| Child–Pugh score * | |
| 5/6/7 | 14 (50)/7 (25)/7 (25) |
| mALBI grade * | |
| 1/2a/2b/3 | 8 (28)/7 (25)/12 (43)/1 (4) |
| Naïve HCC * | |
| Yes/No | 13 (46)/15 (54) |
| BCLC stage * | |
| A/B/C | 3 (11)/10 (36)/15 (53) |
| Size of tumor (cm) † | 5.3 (0.5, 18.5) |
| Number of tumor † | 2 (1, 50) |
| Portal vain invasion * | |
| Yes/No | 7 (25)/21 (75) |
| Metastasis to other organs * | |
| Yes/No | 9 (32)/19 (68) |
| AFP (ng/mL) † | 310 (0.5, 769,600) |
| DCP (mAU/mL) † | 547 (14, 136,617) |
| NLR † | 3.13 (1.19, 25.7) |
† Median (minimum, maximum). * Number of the patients (%). HBV—hepatitis B virus; HCV—hepatitis C virus; non-viral, alcoholic, non-alcoholic steatohepatitis and autoimmune hepatitis; ECOG—Eastern Cooperative Oncology Group; PS—performance status; mALBI—modified albumin–bilirubin; HCC—hepatocellular carcinoma; BCLC—Barcelona Clinic Liver Cancer; AFP—alpha-fetoprotein; DCP—des-gamma-carboxy prothrombin; NLR—neutrophil–to–lymphocyte ratio.